Using 5G technology for follow-up care of heart devices
Official title: Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial
Run by The Third People's Hospital of Chengdu · NCT06652750 · Data updated 2026-11-12
This study is testing if using 5G technology for remote check-ups can be as safe and effective as regular in-person visits for people with heart devices like pacemakers and defibrillators.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 688 (estimated) |
| Sponsor | The Third People's Hospital of Chengdu Academic / other |
| Locations | 2 sites (Guangzhou, Guangdong and 1 other locations) |
| Status | Recruiting |
| Started | November 13, 2024 |
| Main results expected | February 1, 2025 |
| Study ends | February 1, 2026 |
| Registry record updated | November 21, 2024 |
| Trial ID | NCT06652750 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have recently received a cardiovascular implantable electronic device and have not yet undergone their first follow-up.
✕Probably not a fit
Patients with a life expectancy of less than one year or those unable to cooperate with treatment or follow-up will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the safety and effectiveness of 5G cloud follow-up for patients with cardiovascular implantable electronic devices (CIED) such as pacemakers and defibrillators. It employs a prospective, paired, self-controlled, non-inferiority design across multiple centers to compare traditional in-office follow-ups with remote monitoring via 5G technology. Participants will receive both types of follow-up during their regular clinic visits to assess the feasibility and outcomes of remote programming. The study aims to enhance patient monitoring and timely intervention while reducing the need for hospital visits.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management and monitoring of patients with heart devices, leading to better health outcomes.
How similar studies have gone: While remote monitoring has been explored in other studies, the specific application of 5G cloud follow-up for CIEDs is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years, gender unspecified; 2. Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors. 3. Willing to participate in this clinical study and have signed the informed consent form in writing. Exclusion Criteria: * Exclusion Criteria: If meeting any of the following, the individual cannot be included: 1. Life expectancy \< 1 year. 2. Inability to cooperate with treatment or follow-up, such as having mental illness. 3. Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion.
Where it's running
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China Recruiting -
The Third People's Hospital of Chengdu
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Lin Cai, master of medicine
- Email: clin63@yeah.net
- Phone: 8619980510703
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.